Riskpilot← Back to searchSign inGet full accessTJ Biotech Holding ApS
APSActiveCVR 41953616Pile Alle 20Business and other management consultancy activities · NACE 7020Est. 20201 employees
Revenue 2024
DKK 118K
+69% vs 2023
EBITDA margin
42.0%
+354657% vs 2023
Equity ratio
76.1%
Financial strength
Net profit 2024
DKK 668K
+107% vs 2023
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
TJ Biotech Holding ApS 
ResoTher Pharma A/S